This is a non-core endpoint: only basic statistics are computed.
Follicular adenocarcinoma of thyroid gland
C3_THYROID_FOLLICULAR
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
232 |
4. Check minimum number of eventsNone |
232 |
5. Include endpointsNone |
232 |
6. Filter based on genotype QC (FinnGen only) |
223 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Follicular adenocarcinoma of thyroid gland
based on the number of shared cases.
Similar with more cases:
- Follicular adenocarcinoma of thyroid gland, including Hilmo
- Malignant neoplasm of thyroid gland
- Malignant neoplasm of endocrine gland
- Malignant neoplasm of thyroid gland, including Hilmo
- Solid cancers, helper endpoint
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 223 | 138 | 85 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.04 |
| Median age at first event (years) | 51.11 | 47.43 | 57.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 232
- Matched controls
- 2320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
+∞
309.0
222
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
263.7
200
*
104
Kela drug reimbursment
Thyroid insufficiency
71.1
245.2
175
96
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
121.1
225.7
119
20
EP1AE
NOMESCO Finland
Neck ultrasound examination
48.9
169.8
110
42
H03AA01
ATC
levothyroxine sodium; systemic
96.0
160.2
220
372
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
69.1
116.0
65
13
BAA60
NOMESCO Finland
Total thyroidectomy
50.5
104.9
63
17
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
729.8
99.4
91
*
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
226.1
88.1
86
6
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
83.5
75
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
75.2
68
*
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
12.2
42.1
46
46
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
+∞
40.8
38
*
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
+∞
39.7
37
*
ZX114
NOMESCO Finland
Intramuscular
59.9
38.2
44
9
130
Kela drug reimbursment
Malignant tumour
+∞
34.2
32
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.1
33.8
140
532
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
46.5
32.4
39
10
4CJ01, ,
NOMESCO Finland
+∞
27.7
26
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
26.6
25
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.3
26.1
106
381
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
25.5
24
*
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
+∞
24.4
23
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
23.3
22
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
25.3
21.0
29
13
WF049
NOMESCO Finland
Radiotherapy of metastasis
217.8
19.9
20
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
29.5
18.2
24
9
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
16.9
16
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
16.9
16
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
16.9
16
*
XX3DW
NOMESCO Finland
Time consuming IT work
6.2
16.5
30
54
WX402
NOMESCO Finland
General anaesthesia
3.8
16.3
62
205
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
64.7
16.0
18
*
H02AB02
ATC
dexamethasone; systemic
24.1
15.9
22
10
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
14.6
15.1
25
19
JN4AD
NOMESCO Finland
Body CT examination
6.1
14.2
26
47
Z51.88
ICD-10 Finland
Other specified medical care
13.2
14.0
24
20
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
13.7
13
*
1930B
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA FOLLICULARE THYREOIDEAE]
+∞
13.7
13
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
12.6
12
*
WW200
NOMESCO Finland
Immunization
12.0
12.3
22
20
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
11.7
101
522
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
11.6
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
126.0
11.5
12
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
126.0
11.5
12
*
WF002
NOMESCO Finland
Radical radiotherapy
45.6
11.0
13
*
Z51.5
ICD-10 Finland
Palliative care
9.2
10.8
22
26
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
63.0
10.7
12
*
8335/3-C73.9
ICD-O-3
Follicular carcinoma, minimally invasive of thyroid gland
+∞
10.5
10
*
T71
ICPC
Malignant neoplasm thyroid
+∞
10.5
10
*
JN4BD
NOMESCO Finland
Extensive body CT
5.2
10.2
22
46
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
10.1
55
222
A04AA02
ATC
granisetron; systemic, transdermal
104.1
9.5
10
*
106
Kela drug reimbursment
Hypoparathyroidism
104.1
9.5
10
*
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
+∞
9.4
9
*
115
Kela drug reimbursment
Breast cancer
+∞
9.4
9
*
2506
FHL
Thyroidectomy
+∞
9.4
9
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
+∞
9.4
9
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.4
9
*
JN5SN, ,
NOMESCO Finland
+∞
9.4
9
*
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
+∞
8.4
8
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
8.4
8
*
WX704
NOMESCO Finland
Intubation
4.3
8.3
22
55
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
8.1
65
316
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
23.0
8.1
11
5
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
11.4
7.9
14
13
NK6AN
NOMESCO Finland
Total body bone isotope imaging
46.6
7.8
9
*
198
Kela drug reimbursment
Sorafenib
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
116
Kela drug reimbursment
Prostate cancer
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
323
Kela drug reimbursment
Sorafenib
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
N02AA05
ATC
oxycodone; systemic
2.7
7.1
42
175
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
17.3
6.8
10
6
JN6AD
NOMESCO Finland
CT of torso and neck
17.3
6.8
10
6
A03FA01
ATC
metoclopramide; systemic, rectal
2.7
6.7
40
168
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.8
6.5
14
19
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
71.7
6.5
7
*
A11CC03
ATC
alfacalcidol; systemic
8.5
6.4
13
16
WZC30
NOMESCO Finland
Teaching
2.7
6.4
36
146
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
6.3
6
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
27.5
6.3
8
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
58
19
40.37
91.14
1.4
1.2
—
—
—
0
0
177
843
5.64
31.29
12.2
5.3
1.21
1.22
mmol/l
0.92
136
731
167
766
5.21
30.79
9.3
4.9
1.21
1.22
mmol/l
1.43
158
688
133
571
4.12
25.31
4.3
2.0
2.30
2.36
mmol/l
4.20
121
485
54
141
4.69
19.74
2.5
3.9
45.62
78.54
ng/l
5.38
44
127
213
1446
6.78
18.27
12.2
3.9
17.83
14.83
pmol/l
27.53
202
1310
131
764
2.64
11.87
2.6
2.1
—
—
—
0
0
214
1736
4.00
8.38
16.7
4.7
3.33
1.90
mu/l
0.53
203
1593
118
744
2.19
7.92
4.6
3.3
36.62
36.06
g/l
0.62
108
689
41
165
2.80
7.43
3.6
3.2
—
—
—
0
0
180
1381
2.35
6.96
9.8
4.9
76.28
74.64
u/l
0.35
170
1265
116
765
2.03
6.53
2.7
2.4
79.96
76.95
nmol/l
0.62
107
668
119
800
2.00
6.27
15.1
13.8
1.24
1.33
inr
0.58
48
235
16
40
4.22
6.00
1.3
1.8
3.16
5.22
iu/l
—
5
12
137
990
1.94
5.63
8.3
6.4
3.93
4.18
e9/l
0.69
117
854
126
894
1.90
5.39
7.1
3.4
11.15
10.95
umol/l
0.13
117
835
144
1068
1.92
5.36
4.4
3.9
6.35
6.71
mmol/l
1.78
133
981
23
85
2.89
4.84
3.8
1.4
2.58
2.64
ug/l
0.03
18
68
76
481
1.86
4.47
4.9
4.0
0.00
0.00
estimate
-0.00
35
149
16
50
3.36
4.42
2.7
2.2
—
—
—
0
0
63
377
1.92
4.39
2.3
1.8
—
—
—
0
0
28
132
2.28
3.63
1.3
1.3
57.14
108.40
iu/ml
0.64
11
54
99
716
1.67
3.51
4.7
3.7
—
—
—
0
0
14
48
3.04
3.36
4.4
3.8
—
—
—
0
0
8
15
5.48
3.22
1.0
1.5
—
—
—
0
0
87
639
1.58
2.76
2.5
3.0
—
—
—
0
0
10
30
3.44
2.63
1.6
1.1
—
—
—
0
0
7
19
3.76
2.17
1.9
1.2
—
—
—
0
0
7
19
3.76
2.17
1.9
1.2
—
—
—
0
0
205
1878
1.79
2.15
20.3
11.8
19.28
21.42
mg/l
0.47
156
1431
9
31
2.98
2.09
1.7
3.0
59.67
59.42
%
—
9
31
5
10
5.08
2.08
2.2
1.2
—
—
—
0
0
7
20
3.57
2.07
1.4
1.1
—
—
—
0
0
8
26
3.15
2.03
1.8
1.1
—
—
—
0
0
209
1934
1.81
1.99
19.7
14.0
139.77
139.76
mmol/l
0.01
203
1879
209
1935
1.81
1.97
20.3
14.0
3.93
3.97
mmol/l
1.28
201
1882
20
109
1.91
1.84
6.5
4.5
5.46
5.03
kpa
1.83
20
104
94
751
1.42
1.83
4.2
3.7
21.49
47.26
ng/l
2.11
62
518
113
933
1.41
1.83
4.5
3.7
0.00
0.00
estimate
-0.00
35
148
111
915
1.41
1.81
4.5
3.7
0.00
0.00
estimate
-0.00
39
164
9
36
2.56
1.76
1.0
1.3
—
—
—
0
0
9
36
2.56
1.76
1.0
1.3
—
—
—
0
0
44
607
0.66
1.69
5.0
3.6
18.06
7.90
mg/mmol
0.45
29
366
5
14
3.63
1.62
1.6
1.2
—
—
—
0
0
7
156
0.43
1.62
1.4
1.7
—
—
—
0
0
10
43
2.38
1.61
3.4
3.3
26.14
24.48
mmol/l
—
10
43
5
15
3.38
1.53
1.2
1.1
—
—
—
0
0
65
501
1.41
1.51
2.4
2.8
0.31
0.43
e6/l
0.33
51
379
9
38
2.42
1.47
1.9
1.3
54.11
62.11
pmol/l
—
9
38
109
920
1.35
1.45
5.6
5.0
0.00
0.00
estimate
-0.00
35
149
7
29
2.46
1.40
1.1
1.2
—
—
—
0
0
62
775
0.73
1.34
2.2
1.9
92.58
95.92
pmol/l
0.24
34
389
5
18
2.82
1.29
1.4
1.1
—
—
—
0
0
6
25
2.44
1.25
1.7
1.1
—
—
—
0
0
191
1778
1.42
1.23
19.2
10.6
81.09
80.11
ml/min/173m2
0.23
163
1426
52
400
1.39
1.22
1.7
1.8
429.76
451.17
pmol/l
0.20
41
327
37
269
1.45
1.18
2.7
1.7
—
—
—
0
0
5
20
2.53
1.15
1.4
1.8
3.26
191.30
u/ml
—
5
20
7
30
2.37
1.13
2.3
1.9
4.00
13.82
u/ml
—
7
25
31
223
1.45
1.05
2.7
2.2
24.63
21.67
%
0.32
23
200
11
60
1.87
1.04
2.5
1.8
0.30
1.61
ug/l
1.46
11
51
153
1398
1.28
0.98
4.0
4.0
12.82
11.66
mm/h
0.32
137
1278
0
30
0.00
0.98
0.0
1.2
—
3.00
—
0
16
7
37
1.92
0.95
1.3
1.4
—
—
—
0
0
15
226
0.64
0.88
3.8
4.6
31.14
32.52
%
—
7
145
17
112
1.56
0.87
1.4
1.4
—
—
—
0
0
69
584
1.26
0.83
2.3
2.0
99.48
55.87
u/l
0.55
58
538
23
165
1.44
0.81
1.4
3.6
2.48
1.95
mmol/l
0.35
18
134
0
28
0.00
0.76
0.0
1.2
—
1.62
—
0
13
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
26
195
1.38
0.73
1.8
2.3
4.75
5.50
umol/l
0.65
20
164
7
40
1.77
0.72
1.1
1.2
—
—
—
0
0
56
471
1.25
0.71
5.4
3.7
2.69
1.93
ug/l
0.73
49
428
23
171
1.38
0.69
2.7
5.9
1.54
1.59
mmol/l
0.03
16
140
53
445
1.25
0.68
2.7
2.3
3.76
2.97
mg/l
0.84
47
372
5
95
0.52
0.68
5.0
1.8
—
—
—
0
0
5
28
1.80
0.66
1.4
1.5
—
—
—
0
0
46
381
1.26
0.66
4.5
3.5
20.15
24.17
%
1.16
22
179
208
2008
1.35
0.66
12.5
8.3
24.28
25.03
u/l
0.34
201
1931
14
97
1.47
0.60
2.7
5.9
24.36
25.11
mmol/l
0.62
14
91
25
194
1.32
0.59
2.0
1.7
—
—
—
0
0
8
54
1.50
0.58
1.3
1.2
19.46
19.07
iu/l
—
8
47
178
1857
0.82
0.58
4.2
4.4
1.43
1.49
mmol/l
1.10
160
1722
171
1790
0.83
0.57
3.8
3.9
1.37
1.25
mmol/l
1.44
154
1642
8
125
0.63
0.56
1.4
1.3
—
42.71
—
0
10
29
232
1.29
0.56
8.0
6.6
—
—
—
0
0
55
476
1.20
0.54
2.8
2.3
378.00
9430.11
umol/l
2.71
45
417
7
110
0.63
0.49
1.3
1.3
—
—
—
0
0
7
45
1.57
0.49
1.4
1.2
—
—
—
0
0
24
192
1.28
0.47
2.0
1.7
—
—
—
0
0
215
2101
1.32
0.46
29.3
17.5
253.58
249.86
e9/l
0.38
210
2052
215
2101
1.32
0.46
28.9
17.4
40.30
40.35
%
0.04
199
1962
10
69
1.47
0.45
9.7
5.0
27.07
24.93
mmol/l
—
10
63
215
2103
1.30
0.43
29.1
17.5
4.51
4.51
e12/l
0.02
210
2046
5
31
1.63
0.43
2.2
1.5
—
—
—
0
0
5
32
1.57
0.42
1.0
1.4
—
—
—
0
0
181
1871
0.85
0.42
4.3
4.4
4.66
4.63
mmol/l
0.10
164
1743
8
58
1.39
0.42
4.3
1.6
—
—
—
0
0
5
33
1.53
0.41
1.0
1.4
—
—
—
0
0
8
59
1.37
0.41
2.6
1.8
—
—
—
0
0
5
34
1.48
0.40
2.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
32
272
1.20
0.39
3.8
2.5
0.84
0.77
ug/l
0.16
21
180
33
383
0.84
0.38
3.5
3.8
511.52
165.19
ng/l
0.32
25
302
29
245
1.21
0.37
1.8
1.9
29.43
29.77
s
0.13
29
236
9
71
1.28
0.36
6.2
1.3
—
—
—
0
0
6
86
0.69
0.33
1.2
1.5
—
—
—
0
0
187
1919
0.87
0.32
4.7
4.9
2.76
2.72
mmol/l
0.21
168
1782
85
796
1.11
0.28
3.3
2.7
104.19
97.74
ug/l
0.17
76
722
8
62
1.30
0.28
5.0
1.6
—
—
—
0
0
47
517
0.89
0.27
2.0
1.6
1.45
1.36
mmol/l
0.28
35
439
171
1758
0.90
0.27
5.6
5.7
39.51
39.82
mmol/mol
0.20
154
1639
48
438
1.12
0.25
5.5
3.8
1.02
1.02
kg/l
0.29
13
65
37
408
0.89
0.23
1.4
1.7
1.01
1.09
mg/l
0.10
31
305
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
384.73
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
375.80
—
0
5
0
10
0.00
0.21
0.0
1.1
—
1.07
—
0
5
0
10
0.00
0.21
0.0
1.1
—
17.80
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
31
344
0.89
0.21
1.5
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
32
354
0.89
0.21
2.2
1.8
1406.47
1228.45
nmol/l
0.38
22
268
6
51
1.18
0.19
7.2
1.2
0.00
0.00
g/l
—
6
46
61
573
1.09
0.19
3.4
3.1
906.07
1588.20
ng/l
2.09
53
481
19
216
0.87
0.18
2.6
2.2
—
—
—
0
0
10
120
0.83
0.17
1.1
1.2
256.00
364.49
u/ml
—
10
113
26
286
0.90
0.16
1.8
2.9
3.18
3.10
e6/l
0.02
15
149
15
131
1.16
0.15
2.8
2.1
62.67
70.20
ml/min/173m2
—
9
54
41
438
0.92
0.14
1.2
1.3
0.69
2.05
u/ml
1.50
14
112
33
355
0.92
0.13
1.2
1.3
21.23
38.23
iu/ml
1.50
12
119
9
105
0.85
0.13
2.0
2.0
—
—
—
0
0
28
302
0.92
0.12
1.8
2.6
2.00
1.25
e6/l
0.37
17
164
13
115
1.14
0.10
2.1
1.5
—
—
—
0
0
113
1157
0.95
0.10
3.3
3.0
—
—
—
0
0
31
291
1.08
0.10
1.4
1.4
—
—
—
0
0
6
55
1.09
0.09
7.2
1.3
0.00
0.00
g/l
—
6
50
16
146
1.10
0.08
2.4
3.5
284.21
272.50
ng/l
0.02
16
134
10
112
0.89
0.07
1.0
1.1
—
—
—
0
0
7
81
0.86
0.07
1.9
2.0
—
—
—
0
0
124
1220
1.04
0.07
3.2
2.9
41.28
43.11
u/l
0.18
106
1139
10
89
1.13
0.07
1.3
2.6
0.59
0.64
%
—
10
89
185
1865
0.96
0.05
4.4
4.4
5.90
5.94
mmol/l
0.20
166
1706
10
90
1.12
0.05
1.3
2.6
0.90
1.25
%
—
10
90
33
333
0.99
0.00
1.2
1.3
40.28
13.29
u/ml
0.52
12
130
19
190
1.00
-0.00
2.1
2.0
—
—
—
0
0
6
67
0.89
-0.00
1.8
2.2
—
—
—
0
0
5
49
1.02
-0.00
1.0
1.4
260.20
284.98
miu/ml
—
5
23
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
6
64
0.94
-0.00
1.2
1.7
0.21
0.23
g/l
—
6
64
6
65
0.92
-0.00
1.2
1.7
1.10
1.13
g/l
—
6
65
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
10.78
—
0
9
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
224.86
—
0
7
0
9
0.00
-0.00
0.0
3.1
—
640.67
—
0
9
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_THYROID_FOLLICULAR – Follicular adenocarcinoma of thyroid gland
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).